Log In
Print
BCIQ
Print
Print this Print this
 

anti-MARV siRNA, TKM-Marburg

  Manage Alerts
Collapse Summary General Information
Company Tekmira Pharmaceuticals Corp.
DescriptionRNAi therapeutic against Marburg virus formulated with Tekmira's lipid nanoparticle (LNP) siRNA delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationViral infection
Indication DetailsTreat Marburg virus infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today